INHALE-3 extension study: Inhaled technosphere insulin plus insulin degludec maintains glycemic control
A new study in the journal Diabetes Technology & Therapeutics evaluated the effects of a regimen of inhaled technosphere ...
Study suggests inhaled technosphere insulin could be considered as an option for adults with type 1 diabetes
A study in the journal Diabetes Technology & Therapeutics (DTT) concludes that inhaled technosphere insulin (TI-Afrezza) ...
EurekAlert!4d
Results of the INHALE-3 extension study: inhaled technosphere insulin plus insulin degludec in T1D
A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) evaluated the effects of a regimen of inhaled technosphere insulin (TI) and insulin degludec over 30 weeks and its ...
Medscape22d
Patient Satisfaction and Costs Associated With Insulin Administered by Pen Device or Syringe During Hospitalization
A total of 94 patients were eligible for study inclusion and randomization from July 2005 through May 2006; 45 were randomized to the vial and syringe group and 49 were randomized to the insulin ...
Medscape1y
Patient Satisfaction and Costs Associated With Insulin Administered by Pen Device or Syringe During Hospitalization
Study design. This prospective, randomized, controlled, parallel-group study compared the use of pen devices with conventional vials and syringes for the administration of insulin in hospitalized ...